HOME
PIPELINE
INVESTORS
ABOUT US
CONTACT
Back
News
Presentation
CRRT Presentation & Poster
Stock Ticker
Board Diversity Matrix
SEC EDGAR
Back
About Us
Board of Directors
Management
Scientific Advisory Board
Core Values
HOME
PIPELINE
INVESTORS
News
Presentation
CRRT Presentation & Poster
Stock Ticker
Board Diversity Matrix
SEC EDGAR
ABOUT US
About Us
Board of Directors
Management
Scientific Advisory Board
Core Values
CONTACT
Scroll
Rebalancing inflammation
to optimize health
Latest News:
News
Jan 24, 2025
Revelation Biosciences Inc. Announces 1-for-16 Reverse Stock Split effective January 28, 2025
Jan 24, 2025
Read More →
Jan 24, 2025
Jan 21, 2025
Revelation Biosciences Starts its PRIME Phase 1b Clinical Study of Gemini in CKD Patients
Jan 21, 2025
Read More →
Jan 21, 2025
Jan 13, 2025
Revelation Biosciences Inc. Reminds You to Vote for the Special Meeting on January 17, 2025
Jan 13, 2025
Read More →
Jan 13, 2025
Jan 6, 2025
Nasdaq Grants Revelation Biosciences Inc. Continued Listing
Jan 6, 2025
Read More →
Jan 6, 2025
Dec 3, 2024
Revelation Biosciences Inc. Announces Exercise of Warrants for $4 Million in Gross Proceeds
Dec 3, 2024
Read More →
Dec 3, 2024
Welcome
Latest
